No connection

Search Results

BIII

BEARISH
$9.89 Live
Black Spade Acquisition III Co · NYSE
$9.83 52W Range $10.02

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$227.47M
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
18.97
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
BIII exhibits severe financial distress as indicated by a weak Piotroski F-Score of 2/9 and a catastrophic Price/Book ratio of -824.17. As a shell company, it lacks operational revenue and profitability, while maintaining an alarmingly high Debt/Equity ratio of 18.97. The current ratio of 0.88 suggests liquidity constraints, and the technical trend is entirely bearish. The stock is essentially trading at its nominal trust value, but the underlying balance sheet metrics are fundamentally broken.

Key Strengths

Price stability near the $10.00 par value typical of SPACs
Market capitalization provides some scale for potential acquisitions
Recent 1-month price stability (+0.2%)
Clear regulatory filing history (10-K filed March 2026)
Low volatility in the 52-week range

Key Risks

Extreme leverage with a Debt/Equity ratio of 18.97
Negative equity as evidenced by the Price/Book ratio of -824.17
Poor financial health indicated by a Piotroski F-Score of 2/9
Liquidity risk with a Current Ratio below 1.0 (0.88)
Complete lack of operational revenue or earnings growth
AI Fair Value Estimate
Based on comprehensive analysis
$9.85
-0.4% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
13
Weak
Value
5
Future
20
Past
30
Health
10
Dividend
0
AI Verdict
High Risk / Speculative Shell
Key drivers: Negative Book Value, Extreme Debt Levels, Zero Operational Income, Weak Piotroski Score
Confidence
90%
Value
5/100

Graham Number is N/A; valuation is based solely on trust value rather than fundamentals.

Positives
No standout positives identified.
Watchpoints
  • Price/Book is -824.17
  • No P/E or PEG available due to zero earnings
Future
20/100

Future value is binary, depending entirely on a successful business combination.

Positives
  • Potential for a merger target
Watchpoints
  • No revenue growth
  • No earnings growth
Past
30/100

Historical performance reflects a stagnant shell company.

Positives
  • Price has remained relatively flat
Watchpoints
  • 1Y change is negative (-0.9%)
  • No historical growth trajectory
Health
10/100

Health is critical; the company is heavily leveraged with poor liquidity.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 2/9
  • Debt/Equity 18.97
  • Current Ratio 0.88
Dividend
0/100

Typical for shell companies; no income generation.

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • No payout history

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$9.89

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BIII and closest competitors.

Updated 2026-04-24
BII
Black Spade Acquisition III Co
Primary
5Y
-0.9%
3Y
-0.9%
1Y
-0.9%
6M
-0.9%
1M
+0.2%
1W
+0.2%
CBN
Chain Bridge Bancorp, Inc.
Peer
5Y
+65.6%
3Y
+65.6%
1Y
+44.0%
6M
+12.6%
1M
-0.8%
1W
-2.3%
HWB
Hawthorn Bancshares, Inc.
Peer
5Y
+95.2%
3Y
+65.3%
1Y
+20.3%
6M
+14.9%
1M
-1.5%
1W
-2.5%
AIF
AIFU Inc.
Peer
5Y
-99.3%
3Y
-98.8%
1Y
-75.2%
6M
-67.8%
1M
+11.1%
1W
+4.6%
PEB
Peoples Bancorp of North Carolina, Inc.
Peer
5Y
+110.8%
3Y
+57.0%
1Y
+67.5%
6M
+41.6%
1M
+12.8%
1W
+0.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
-824.17
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$227.47M

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
18.97
High debt
Current Ratio
0.88
Weak
Quick Ratio
0.88
Poor
Cash/Share
$N/A

Financial Services Sector Comparison

Comparing BIII against 648 companies in the Financial Services sector (117 bullish, 268 neutral, 263 bearish)
Debt to Equity
18.97
This Stock
vs
1.52
Sector Avg
+1147.1% (Higher)
Current Ratio
0.88
This Stock
vs
3.62
Sector Avg
-75.7% (Weaker)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-K
10-K
2026-03-06

BIII filed its 10-K on March 6, 2026, which includes sections on business operations, risk factors, and management's discussion and analysis of financial condition. No specific financial highlights or risk details were provided in the available excerpts.

10-Q
10-Q
2026-02-19

BIII filed its 10-Q on February 19, 2026. The provided excerpt identifies the existence of Risk Factors under Item 1A, although no specific financial highlights or detailed risk descriptions were included in the available text.

8-K
FORM 8-K
2026-01-26

BioLineRx Ltd. (BIII) filed an 8-K, likely to announce preliminary financial results or a material corporate update for the fiscal year ended December 31, 2025.

8-K/A
FORM 8-K/A
2026-01-16

BioXcel Therapeutics, Inc. (BIII) filed an amendment to a previously submitted Form 8-K.

8-K
FORM 8-K
2026-01-13
8-K
FORM 8-K
2026-01-09
S-1/A
FORM S-1/A
2026-01-05

BIII filed an amended registration statement (Form S-1/A) on January 5, 2026, in connection with its proposed initial public offering.

S-1/A
S-1/A
2025-12-18

BIII filed an amended registration statement (Form S-1/A) on December 18, 2025, in connection with its proposed initial public offering.

S-1/A
FORM S-1/A
2025-12-12

BIII filed an amended registration statement (Form S-1/A) on December 12, 2025, as part of its process to register securities for a public offering.

S-1/A
S-1/A
2025-12-05

BIII filed an amended registration statement (Form S-1/A) on December 5, 2025, in connection with its proposed initial public offering.

S-1
S-1
2025-09-30
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning BIII from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile